Endoscopic and Radiographic Assessment of Crohn's Disease

Gastroenterology Clinics of North America

Volumn 46, Issue 3, 2017, Pages 493-513

  Al Bawardy, Badr ^a   Hansel, Stephanie L ^a   Fidler, Jeff L ^a   Barlow, John M ^a   Bruining, David H ^a  

^a MAYO CLINIC   (United States)

Author keywords

Computed tomography; Crohn's disease; Endoscopy; Enterography; MRI; Mucosal healing; Ultrasound

Indexed keywords

ADALIMUMAB; INFLIXIMAB; TUMOR NECROSIS FACTOR INHIBITOR; CORTICOSTEROID;

ANUS FISTULA; BALLOON ENTEROSCOPY; CAPSULE ENDOSCOPY; CAPSULE ENDOSCOPY CROHN DISEASE ACTIVITY INDEX; CLERMONT FERRAND INDEX; COMPUTED TOMOGRAPHY ENTEROGRAPHY; CROHN DISEASE; CROHN DISEASE ACTIVITY INDEX; CROHN DISEASE ENDOSCOPIC INDEX OF SEVERITY; CROHN DISEASE MAGNETIC RESONANCE IMAGING INDEX; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; DISEASE ACTIVITY; DISEASE SEVERITY; ECHOGRAPHY; ENDOSCOPY; ESOPHAGOGASTRODUODENOSCOPY; HUMAN; ILEOCOLONOSCOPY; LEMANN INDEX; LEWIS SCORE; MAGNETIC RESONANCE ENTEROGRAPHY; MAGNETIC RESONANCE ENTEROGRAPHY GLOBAL SCORE; MAGNETIC RESONANCE IMAGING PERIANAL FISTULA; MAGNETIC RESONANCE INDEX OF ACTIVITY SCORE; NANCY SCORE; REVIEW; RUTGEERTS SCORE; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SIMPLE ENDOSCOPIC SCORE FOR CROHN DISEASE; TREATMENT RESPONSE; ABDOMINAL SURGERY; GASTROINTESTINAL ENDOSCOPY; HOSPITALIZATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROGNOSIS; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; X-RAY COMPUTED TOMOGRAPHY;

ADRENAL CORTEX HORMONES; CROHN DISEASE; DIGESTIVE SYSTEM SURGICAL PROCEDURES; ENDOSCOPY, GASTROINTESTINAL; HOSPITALIZATION; HUMANS; MAGNETIC RESONANCE IMAGING; PROGNOSIS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY;

EID: 85028674048     PISSN: 08898553     EISSN: 15581942     Source Type: Journal    
DOI: 10.1016/j.gtc.2017.05.005     Document Type: Review

References (56)

1. Modigliani, R., Mary, J.Y., Simon, J.F., et al. Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives. Gastroenterology 98:4 (1990), 811–818.
2. Jones, J., Loftus, E.V. Jr., Panaccione, R., et al. Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease. Clin Gastroenterol Hepatol 6:11 (2008), 1218–1224.
3. Hanauer, S.B., Feagan, B.G., Lichtenstein, G.R., et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 359:9317 (2002), 1541–1549.
4. Colombel, J.F., Sandborn, W.J., Reinisch, W., et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med 362:15 (2010), 1383–1395.
5. Deepak, P., Fletcher, J.G., Fidler, J.L., et al. Radiological response is associated with better long-term outcomes and is a potential treatment target in patients with small bowel Crohn's Disease. Am J Gastroenterol 111:7 (2016), 997–1006.
6. Reinink, A.R., Lee, T.C., Higgins, P.D., Endoscopic mucosal healing predicts favorable clinical outcomes in inflammatory bowel disease: a meta-analysis. Inflamm Bowel Dis 22:8 (2016), 1859–1869.
7. Annunziata, M.L., Caviglia, R., Papparella, L.G., et al. Upper gastrointestinal involvement of Crohn's disease: a prospective study on the role of upper endoscopy in the diagnostic work-up. Dig Dis Sci 57:6 (2012), 1618–1623.
8. Dionisio, P.M., Gurudu, S.R., Leighton, J.A., et al. Capsule endoscopy has a significantly higher diagnostic yield in patients with suspected and established small-bowel Crohn's disease: a meta-analysis. Am J Gastroenterol 105:6 (2010), 1240–1248 [quiz: 1249].
9. Jensen, M.D., Nathan, T., Rafaelsen, S.R., et al. Diagnostic accuracy of capsule endoscopy for small bowel Crohn's disease is superior to that of MR enterography or CT enterography. Clin Gastroenterol Hepatol 9:2 (2011), 124–129.
10. Liao, Z., Gao, R., Xu, C., et al. Indications and detection, completion, and retention rates of small-bowel capsule endoscopy: a systematic review. Gastrointest Endosc 71:2 (2010), 280–286.
11. Pennazio, M., Spada, C., Eliakim, R., et al. Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel disorders: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy 47:4 (2015), 352–376.
12. Shah, S.C., Colombel, J.F., Sands, B.E., et al. Systematic review with meta-analysis: mucosal healing is associated with improved long-term outcomes in Crohn's disease. Aliment Pharmacol Ther 43:3 (2016), 317–333.
13. Neurath, M.F., Travis, S.P., Mucosal healing in inflammatory bowel diseases: a systematic review. Gut 61:11 (2012), 1619–1635.
14. Casellas, F., Barreiro de Acosta, M., Iglesias, M., et al. Mucosal healing restores normal health and quality of life in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 24:7 (2012), 762–769.
15. Schnitzler, F., Fidder, H., Ferrante, M., et al. Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease. Inflamm Bowel Dis 15:9 (2009), 1295–1301.
16. Mary, J.Y., Modigliani, R., Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID). Gut 30:7 (1989), 983–989.
17. Khanna, R., Zou, G., D'Haens, G., et al. Reliability among central readers in the evaluation of endoscopic findings from patients with Crohn's disease. Gut 65:7 (2016), 1119–1125.
18. Vuitton, L., Marteau, P., Sandborn, W.J., et al. IOIBD technical review on endoscopic indices for Crohn's disease clinical trials. Gut 65:9 (2016), 1447–1455.
19. Peyrin-Biroulet, L., Panes, J., Sandborn, W.J., et al. Defining disease severity in inflammatory bowel diseases: current and future directions. Clin Gastroenterol Hepatol 14:3 (2016), 348–354.
20. Ferrante, M., Colombel, J.F., Sandborn, W.J., et al. Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC. Gastroenterology 145:5 (2013), 978–986.
21. Daperno, M., D'Haens, G., Van Assche, G., et al. Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD. Gastrointest Endosc 60:4 (2004), 505–512.
22. Buisson, A., Chevaux, J.B., Allen, P.B., et al. Review article: the natural history of postoperative Crohn's disease recurrence. Aliment Pharmacol Ther 35:6 (2012), 625–633.
23. Rutgeerts, P., Geboes, K., Vantrappen, G., et al. Predictability of the postoperative course of Crohn's disease. Gastroenterology 99:4 (1990), 956–963.
24. Marteau, P., Laharie, D., Colombel, J.F., et al. Interobserver variation study of the Rutgeerts score to assess endoscopic recurrence after surgery for Crohn's disease. J Crohns Colitis 10:9 (2016), 1001–1005.
25. Gralnek, I.M., Defranchis, R., Seidman, E., et al. Development of a capsule endoscopy scoring index for small bowel mucosal inflammatory change. Aliment Pharmacol Ther 27:2 (2008), 146–154.
26. Cotter, J., Dias de Castro, F., Magalhaes, J., et al. Validation of the Lewis score for the evaluation of small-bowel Crohn's disease activity. Endoscopy 47:4 (2015), 330–335.
27. Gal, E., Geller, A., Fraser, G., et al. Assessment and validation of the new capsule endoscopy Crohn's disease activity index (CECDAI). Dig Dis Sci 53:7 (2008), 1933–1937.
28. Niv, Y., Ilani, S., Levi, Z., et al. Validation of the Capsule Endoscopy Crohn's Disease Activity Index (CECDAI or Niv score): a multicenter prospective study. Endoscopy 44:1 (2012), 21–26.
29. Panes, J., Bouzas, R., Chaparro, M., et al. Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn's disease. Aliment Pharmacol Ther 34:2 (2011), 125–145.
30. Siddiki, H., Fletcher, J.G., Hara, A.K., et al. Validation of a lower radiation computed tomography enterography imaging protocol to detect Crohn's disease in the small bowel. Inflamm Bowel Dis 17:3 (2011), 778–786.
31. Siddiki, H.A., Fidler, J.L., Fletcher, J.G., et al. Prospective comparison of state-of-the-art MR enterography and CT enterography in small-bowel Crohn's disease. AJR Am J Roentgenol 193:1 (2009), 113–121.
32. Samuel, S., Bruining, D.H., Loftus, E.V. Jr., et al. Endoscopic skipping of the distal terminal ileum in Crohn's disease can lead to negative results from ileocolonoscopy. Clin Gastroenterol Hepatol 10:11 (2012), 1253–1259.
33. Bruining, D.H., Siddiki, H.A., Fletcher, J.G., et al. Prevalence of penetrating disease and extraintestinal manifestations of Crohn's disease detected with CT enterography. Inflamm Bowel Dis 14:12 (2008), 1701–1706.
34. Bruining, D.H., Siddiki, H.A., Fletcher, J.G., et al. Benefit of computed tomography enterography in Crohn's disease: effects on patient management and physician level of confidence. Inflamm Bowel Dis 18:2 (2012), 219–225.
35. Siddiqui, M.R., Ashrafian, H., Tozer, P., et al. A diagnostic accuracy meta-analysis of endoanal ultrasound and MRI for perianal fistula assessment. Dis Colon Rectum 55:5 (2012), 576–585.
36. Schwartz, D.A., Wiersema, M.J., Dudiak, K.M., et al. A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn's perianal fistulas. Gastroenterology 121:5 (2001), 1064–1072.
37. Castiglione, F., Mainenti, P.P., De Palma, G.D., et al. Noninvasive diagnosis of small bowel Crohn's disease: direct comparison of bowel sonography and magnetic resonance enterography. Inflamm Bowel Dis 19:5 (2013), 991–998.
38. Calabrese, E., La Seta, F., Buccellato, A., et al. Crohn's disease: a comparative prospective study of transabdominal ultrasonography, small intestine contrast ultrasonography, and small bowel enema. Inflamm Bowel Dis 11:2 (2005), 139–145.
39. Castiglione, F., Bucci, L., Pesce, G., et al. Oral contrast-enhanced sonography for the diagnosis and grading of postsurgical recurrence of Crohn's disease. Inflamm Bowel Dis 14:9 (2008), 1240–1245.
40. Calabrese, E., Petruzziello, C., Onali, S., et al. Severity of postoperative recurrence in Crohn's disease: correlation between endoscopic and sonographic findings. Inflamm Bowel Dis 15:11 (2009), 1635–1642.
41. Rimola, J., Rodriguez, S., Garcia-Bosch, O., et al. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease. Gut 58:8 (2009), 1113–1120.
42. Rimola, J., Ordas, I., Rodriguez, S., et al. Magnetic resonance imaging for evaluation of Crohn's disease: validation of parameters of severity and quantitative index of activity. Inflamm Bowel Dis 17:8 (2011), 1759–1768.
43. Ordas, I., Rimola, J., Rodriguez, S., et al. Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease. Gastroenterology 146:2 (2014), 374–382.
44. Steward, M.J., Punwani, S., Proctor, I., et al. Non-perforating small bowel Crohn's disease assessed by MRI enterography: derivation and histopathological validation of an MR-based activity index. Eur J Radiol 81:9 (2012), 2080–2088.
45. Makanyanga, J.C., Pendse, D., Dikaios, N., et al. Evaluation of Crohn's disease activity: initial validation of a magnetic resonance enterography global score (MEGS) against faecal calprotectin. Eur Radiol 24:2 (2014), 277–287.
46. Prezzi, D., Bhatnagar, G., Vega, R., et al. Monitoring Crohn's disease during anti-TNF-alpha therapy: validation of the magnetic resonance enterography global score (MEGS) against a combined clinical reference standard. Eur Radiol 26:7 (2016), 2107–2117.
47. Oussalah, A., Laurent, V., Bruot, O., et al. Diffusion-weighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease. Gut 59:8 (2010), 1056–1065.
48. Peyrin-Biroulet, L., Laurent, V., Is diffusion-weighted Magnetic Resonance Imaging for assessing Crohn's disease ready for prime time? Experience with the Nancy Score. Inflamm Bowel Dis, 21(10), 2015, E25.
49. Buisson, A., Joubert, A., Montoriol, P.F., et al. Diffusion-weighted magnetic resonance imaging for detecting and assessing ileal inflammation in Crohn's disease. Aliment Pharmacol Ther 37:5 (2013), 537–545.
50. Hordonneau, C., Buisson, A., Scanzi, J., et al. Diffusion-weighted magnetic resonance imaging in ileocolonic Crohn's disease: validation of quantitative index of activity. Am J Gastroenterol 109:1 (2014), 89–98.
51. Van Assche, G., Vanbeckevoort, D., Bielen, D., et al. Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease. Am J Gastroenterol 98:2 (2003), 332–339.
52. Karmiris, K., Bielen, D., Vanbeckevoort, D., et al. Long-term monitoring of infliximab therapy for perianal fistulizing Crohn's disease by using magnetic resonance imaging. Clin Gastroenterol Hepatol 9:2 (2011), 130–136.
53. Rigazio, C., Ercole, E., Laudi, C., et al. Abdominal bowel ultrasound can predict the risk of surgery in Crohn's disease: proposal of an ultrasonographic score. Scand J Gastroenterol 44:5 (2009), 585–593.
54. Calabrese, E., Zorzi, F., Zuzzi, S., et al. Development of a numerical index quantitating small bowel damage as detected by ultrasonography in Crohn's disease. J Crohns Colitis 6:8 (2012), 852–860.
55. Zorzi, F., Stasi, E., Bevivino, G., et al. A sonographic lesion index for Crohn's disease helps monitor changes in transmural bowel damage during therapy. Clin Gastroenterol Hepatol 12:12 (2014), 2071–2077.
56. Pariente, B., Mary, J.Y., Danese, S., et al. Development of the Lemann index to assess digestive tract damage in patients with Crohn's disease. Gastroenterology 148:1 (2015), 52–63.e3.